Phase 3 N=45 Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)
Polycystic Ovary Syndrome
Primary: Number of Menses During the Six Month Study Period. — .42; .42; .75; .25 Number of menstrual cycles per month
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=478 Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients
Anemia
Primary: To Compare the Efficacy of HX575 Hexal AG and ERYPO® Janssen-Cilag. — 0.147; 0.063 g/dL
Phase 2 N=12 T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Vaginal Cancer · Cervical Cancer · Anal Cancer
Primary: Maximum Tolerated Dose (MTD) — 2 # of cells x 10^11
N/A N=395 Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
Pregnancy · Fetal Macrosomia · Intrauterine Growth Restriction
Primary: Fetal Weight (Fetal Weight at Birth) — 3243 gram
N/A N=54 Clinical Reasoning Process of Physiotherapists When Observing Hemiplegic Gait
Stroke
Primary: Number of Gait Abnormalities Observed — 177 number of different gait abnormalities
N/A N=348 A Helping Hand Among Low-Income Patients
Depression · Diabetes · Heart Disease
Primary: Response Rate - 50 Percent or Greater Reduction in Patient Health Survey-9 (PHQ-9) Score Since Baseline — 69; 68; 67; 60 Participants
N/A N=31 Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms
Aortic Aneurysm, Thoracic
Primary: Number of Participants With Successful Study Device Access — 31 Participants
Phase 3 N=70 Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment
Inflammation of Mouth · Acute Mucous Inflammation
Primary: Wound Size (mm^2) Reduction — 11.26; 8.92 mm^2
N/A N=35 SSRI Effects on Semen Parameters in Men
Healthy
Primary: Semen Volume — 2.55 mL
Phase 4 N=20 Liposomal Bupivacaine in Simultaneous Bilateral Total Knee Arthroplasty
Arthroplasty, Replacement, Knee · Pain
Primary: Adverse Events — 0 participants
N/A N=41 Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
Primary: Changes in Respiratory Rate — 15.93; 17.18; 21.31; 18.73 Breaths per minute — p=0.05
Phase 2 N=293 A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis
Psoriasis
Primary: Percentage of Participants With Physician Global Assessment (PGA) Score of Cleared (0) or Minimal (1) at Week 16 — 7.1; 34.1; 61.0; 78.6 percentage of participants…
N/A N=209 Measuring the Context of Healing in Chronic Pain Treatment
Chronic Pain
Primary: PROMIS Pain Intensity — 50.1; 52.9 T-score metric
Phase 2 N=16 Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke
Stroke
Primary: Change From Baseline Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Score — 6.86; 1.29 standard score change
Phase 3 N=424 Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
Psoriatic Arthritis
Primary: Proportion of ACR 20 Responders at Day 169 — 39.4; 22.3 Percentage of participants — p=<0.001